Health regulators must carefully monitor the real-world safety and effectiveness of marketed
vaccines through post-market monitoring in order to protect the public's health and promote …

Objectives: The aim of this study was to assess the way that doctors themselves, who often
deal with human papilloma virus, embrace the subject from a personal perspective …

Breast cancer is the second most common cause of cancer death among women (Mahon,
2012; Tirona, 2013). Recent research related to benefits and harms of screening …

Intense research activity in HPV modelling over this decade has prompted the development
of additional guidelines to those for general modelling. A specific framework is required to …

Résumé En 2018, la province de Québec a modifié son calendrier de vaccination contre les
virus du papillome humain (VPH), remplaçant le calendrier comportant 2 doses de vaccin …

Opportunities exist to improve public health prevention of new HIV and HPV infections. This
thesis used different economic analytical methods, including cost-effectiveness, budget …

Hispanic Americans experience a disparate burden of human papillomavirus vaccination
(HPV)-related cancers. Despite vaccine availability, HPV vaccine uptake amid Hispanic …

As the marginal clinical impact returns on innovations to treat and prevent HIV diminish,
strategic investments are required for timely and efficient HIV eradication. The overall goal of …

Pavitt, Charlotte; Public Health England Postma, Maarten; University of Groningen,
Department of Pharmacy; University of Groningen, Department of Health Sciences Jit, Mark; …

Addition of the Human Papillomavirus (HPV) vaccine to available cytological screening has
been proposed to increase HPV-related cancer prevention. A comprehensive review on this …